1,2-distearoylphosphatidylethanolamine and Lung Injury, Acute

1,2-distearoylphosphatidylethanolamine has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aljuffali, IA; Fang, CL; Fang, JY; Huang, CL; Sung, CT; Wen, CJ	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Lung Injury, Acute

Article	Year
Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study. Journal of controlled release : official journal of the Controlled Release Society, 2015, Sep-10, Volume: 213 Topics: Acute Lung Injury; Adult; Animals; Cells, Cultured; Drug Carriers; Drug Delivery Systems; Humans; Lung; Male; Mice, Inbred C57BL; Phosphatidylcholines; Phosphatidylethanolamines; Phosphodiesterase 4 Inhibitors; Polyethylene Glycols; Rats, Sprague-Dawley; Rolipram; Tissue Distribution; Young Adult	2015

Article

Year

Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study.

Journal of controlled release : official journal of the Controlled Release Society, 2015, Sep-10, Volume: 213

Topics: Acute Lung Injury; Adult; Animals; Cells, Cultured; Drug Carriers; Drug Delivery Systems; Humans; Lung; Male; Mice, Inbred C57BL; Phosphatidylcholines; Phosphatidylethanolamines; Phosphodiesterase 4 Inhibitors; Polyethylene Glycols; Rats, Sprague-Dawley; Rolipram; Tissue Distribution; Young Adult

2015